Stute, M.;                     Kreysing, M.;                     Zorn, M.;                     Michl, P.;                     Gauss, A.    
        Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein. Int. J. Mol. Sci. 2024, 25, 1177.
    https://doi.org/10.3390/ijms25021177
    AMA Style
    
                                Stute M,                                 Kreysing M,                                 Zorn M,                                 Michl P,                                 Gauss A.        
                Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein. International Journal of Molecular Sciences. 2024; 25(2):1177.
        https://doi.org/10.3390/ijms25021177
    
    Chicago/Turabian Style
    
                                Stute, Marie,                                 Martin Kreysing,                                 Markus Zorn,                                 Patrick Michl,                                 and Annika Gauss.        
                2024. "Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein" International Journal of Molecular Sciences 25, no. 2: 1177.
        https://doi.org/10.3390/ijms25021177
    
    APA Style
    
                                Stute, M.,                                 Kreysing, M.,                                 Zorn, M.,                                 Michl, P.,                                 & Gauss, A.        
        
        (2024). Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein. International Journal of Molecular Sciences, 25(2), 1177.
        https://doi.org/10.3390/ijms25021177